BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33151743)

  • 1. LC-MS/MS assays to quantify sulfatides and lysosulfatide in cerebrospinal fluid of metachromatic leukodystrophy patients.
    Cao KH; Zhang G; Jacobsen L; Wu J
    Bioanalysis; 2020 Nov; 12(22):1621-1633. PubMed ID: 33151743
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry.
    Mirzaian M; Kramer G; Poorthuis BJ
    J Lipid Res; 2015 Apr; 56(4):936-43. PubMed ID: 25632048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy.
    Farah MH; Dali CÍ; Groeschel S; Moldovan M; Whiteman DAH; Malanga CJ; Krägeloh-Mann I; Li J; Barton N; Krarup C
    Ann Clin Transl Neurol; 2024 Feb; 11(2):328-341. PubMed ID: 38146590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved synthesis of [1-14C]acyl-sphingosine-galactose-3-sulfate (sulfatide) for diagnosis of metachromatic leukodystrophy: usefulness of radioscanning.
    Masson M; Li WX; Fluharty AL; Beaucourt JP; Turpin JC; Baumann N
    Clin Chim Acta; 1991 Sep; 201(3):157-68. PubMed ID: 1684534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice.
    Blomqvist M; Gieselmann V; Månsson JE
    Lipids Health Dis; 2011 Feb; 10():28. PubMed ID: 21299873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy.
    Toda K; Kobayashi T; Goto I; Ohno K; Eto Y; Inui K; Okada S
    J Neurochem; 1990 Nov; 55(5):1585-91. PubMed ID: 1976756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of lysosulfatide (sulfogalactosylsphingosine) in tissues of a boy with metachromatic leukodystrophy.
    Toda K; Kobayashi T; Goto I; Kurokawa T; Ogomori K
    Biochem Biophys Res Commun; 1989 Mar; 159(2):605-11. PubMed ID: 2539117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-performance liquid chromatography/tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy.
    Han M; Jun SH; Song SH; Park HD; Park KU; Song J
    Rapid Commun Mass Spectrom; 2014 Mar; 28(6):587-94. PubMed ID: 24519821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy.
    Kuchař L; Asfaw B; Poupětová H; Honzíková J; Tureček F; Ledvinová J
    Clin Chim Acta; 2013 Oct; 425():153-9. PubMed ID: 23838369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of sulfatides in dried blood and urine spots from metachromatic leukodystrophy patients by liquid chromatography/electrospray tandem mass spectrometry.
    Barcenas M; Suhr TR; Scott CR; Turecek F; Gelb MH
    Clin Chim Acta; 2014 Jun; 433():39-43. PubMed ID: 24370383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain.
    Rosengren B; Fredman P; Månsson JE; Svennerholm L
    J Neurochem; 1989 Apr; 52(4):1035-41. PubMed ID: 2926387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and composition of sulfatides isolated from livers of patients with metachromatic leukodystrophy: galactosyl sulfatide and lactosyl sulfatide.
    Sugita M; Dulaney JT; Moser HW
    J Lipid Res; 1974 May; 15(3):227-33. PubMed ID: 4363968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
    Babcock MC; Mikulka CR; Wang B; Chandriani S; Chandra S; Xu Y; Webster K; Feng Y; Nelvagal HR; Giaramita A; Yip BK; Lo M; Jiang X; Chao Q; Woloszynek JC; Shen Y; Bhagwat S; Sands MS; Crawford BE
    Sci Rep; 2021 Jul; 11(1):14486. PubMed ID: 34262084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry.
    Whitfield PD; Sharp PC; Johnson DW; Nelson P; Meikle PJ
    Mol Genet Metab; 2001 May; 73(1):30-7. PubMed ID: 11350180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of plasma sulfatides by mass spectrometry: Utility for metachromatic leukodystrophy.
    Saville JT; Smith NJ; Fletcher JM; Fuller M
    Anal Chim Acta; 2017 Feb; 955():79-85. PubMed ID: 28088283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel LC-MS/MS assay to quantify dermatan sulfate in cerebrospinal fluid as a biomarker for mucopolysaccharidosis II.
    Pan P; Chen M; Zhang Z; Corte AD; Souza C; Giugliani R; Pan L; Qiu Y; Amaravadi L; Wu J
    Bioanalysis; 2018 Jun; 10(11):825-838. PubMed ID: 29863901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfatide Analysis by Mass Spectrometry for Screening of Metachromatic Leukodystrophy in Dried Blood and Urine Samples.
    Spacil Z; Babu Kumar A; Liao HC; Auray-Blais C; Stark S; Suhr TR; Scott CR; Turecek F; Gelb MH
    Clin Chem; 2016 Jan; 62(1):279-86. PubMed ID: 26585924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioanalytical method development and validation for the determination of glycine in human cerebrospinal fluid by ion-pair reversed-phase liquid chromatography-tandem mass spectrometry.
    Jiang J; James CA; Wong P
    J Pharm Biomed Anal; 2016 Sep; 128():132-140. PubMed ID: 27262106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease).
    Suzuki K
    Neuropediatrics; 1984 Sep; 15 Suppl():32-6. PubMed ID: 6152811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfogalactosylceramides in motor and psycho-cognitive adult metachromatic leukodystrophy: relations between clinical, biochemical analysis and molecular aspects.
    Colsch B; Afonso C; Turpin JC; Portoukalian J; Tabet JC; Baumann N
    Biochim Biophys Acta; 2008 Mar; 1780(3):434-40. PubMed ID: 17980709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.